September 2008
Practice TipDefeating the Fraudulent
By Lori G. Cohen and John B. Merchant, III
Over the past decade, plaintiffs have stepped up their assaults on federal diversity jurisdiction in pharmaceutical and medical device litigation. Along with their efforts to chip away at the learned intermediary doctrine, plaintiffs increasingly are attempting to join local sales representatives fraudulently in order to defeat diversity.
Subscribers: click here for the full story
Non-Subscribers: click here to subscribe
Pay per view ($20.00)
